Serum midkine levels for the diagnosis and assessment of response to interventional therapy in patients with hepatocellular carcinoma.

Journal: Journal of interventional medicine
Published Date: Oct 12, 2020

Abstract

OBJECTIVE: To explore the clinical significance of serum midkine (MDK) levels for the diagnosis of hepatocellular carcinoma (HCC) and evaluate the efficacy of interventional therapy.

Authors

  • Lin Zheng
    Department of Minimally Invasive Intervention, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, 450008, China.
  • Hailiang Li
    Department of Minimally Invasive Intervention, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, 450008, China.
  • Jinhua Huang
    Division of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Jihoon Shin
    Department of Radiology and Research Institute of Radiology, University of Ulsan, College of Medicine, Asan Medical Center, 86, Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, Republic of Korea.
  • Suxia Luo
    Department of Medical Gastroenterology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, 450008, China.
  • Chenyang Guo
    Department of Minimally Invasive Intervention, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, 450008, China.
  • Yan Zhao
    Emergency Center, Hubei Clinical Research Center for Emergency and Resuscitaion, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Fangkun Li
    Department of Minimally Invasive Intervention, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, 450008, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals